Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Apolipoprotein C-III | 44 | 2023 | 209 | 8.820 |
Why?
|
Lipoproteins, HDL | 40 | 2024 | 676 | 6.610 |
Why?
|
Diet, Reducing | 60 | 2024 | 487 | 5.260 |
Why?
|
Lipoproteins, VLDL | 31 | 2023 | 198 | 4.350 |
Why?
|
Coronary Disease | 63 | 2022 | 5919 | 4.230 |
Why?
|
Apolipoproteins B | 29 | 2023 | 385 | 4.120 |
Why?
|
Cholesterol, HDL | 47 | 2023 | 1813 | 4.020 |
Why?
|
Weight Loss | 65 | 2024 | 2711 | 3.910 |
Why?
|
Lipoproteins, LDL | 32 | 2023 | 642 | 3.700 |
Why?
|
Apolipoproteins E | 22 | 2023 | 1459 | 3.440 |
Why?
|
Hypertriglyceridemia | 16 | 2016 | 292 | 3.440 |
Why?
|
Dietary Fats | 62 | 2022 | 2003 | 3.410 |
Why?
|
Pravastatin | 47 | 2014 | 391 | 3.370 |
Why?
|
Dietary Carbohydrates | 31 | 2024 | 896 | 3.180 |
Why?
|
Apolipoprotein A-I | 19 | 2024 | 305 | 3.090 |
Why?
|
Triglycerides | 54 | 2023 | 2441 | 3.070 |
Why?
|
Dietary Fats, Unsaturated | 15 | 2019 | 223 | 2.990 |
Why?
|
Anticholesteremic Agents | 37 | 2021 | 970 | 2.920 |
Why?
|
Lipoproteins | 32 | 2023 | 870 | 2.820 |
Why?
|
Overweight | 50 | 2024 | 2444 | 2.620 |
Why?
|
Dietary Proteins | 31 | 2024 | 960 | 2.410 |
Why?
|
Diet, Fat-Restricted | 25 | 2024 | 328 | 2.390 |
Why?
|
Apolipoproteins C | 11 | 2006 | 58 | 2.320 |
Why?
|
Diet, Carbohydrate-Restricted | 7 | 2024 | 263 | 2.270 |
Why?
|
Cholesterol | 56 | 2023 | 2902 | 2.220 |
Why?
|
Obesity | 72 | 2024 | 13085 | 2.210 |
Why?
|
Cholesterol, LDL | 47 | 2024 | 2395 | 2.200 |
Why?
|
Apolipoproteins | 14 | 2023 | 327 | 1.950 |
Why?
|
Cardiovascular Diseases | 72 | 2024 | 15647 | 1.910 |
Why?
|
Insulin Resistance | 27 | 2024 | 3988 | 1.680 |
Why?
|
Hypolipidemic Agents | 13 | 2019 | 609 | 1.590 |
Why?
|
Diet, Mediterranean | 8 | 2024 | 746 | 1.550 |
Why?
|
Diet, Sodium-Restricted | 14 | 2023 | 291 | 1.530 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 35 | 2024 | 3249 | 1.280 |
Why?
|
Atherosclerosis | 19 | 2024 | 3418 | 1.270 |
Why?
|
Diet | 47 | 2023 | 8087 | 1.220 |
Why?
|
Hyperlipidemias | 11 | 2021 | 770 | 1.190 |
Why?
|
Glycemic Index | 7 | 2023 | 400 | 1.190 |
Why?
|
Blood Pressure | 56 | 2023 | 8532 | 1.130 |
Why?
|
Cholesterol Ester Transfer Proteins | 8 | 2021 | 113 | 1.110 |
Why?
|
Hypertension | 53 | 2023 | 8616 | 1.100 |
Why?
|
American Heart Association | 16 | 2021 | 1045 | 1.050 |
Why?
|
Diabetes Mellitus, Type 2 | 27 | 2023 | 12235 | 1.030 |
Why?
|
Lipid Metabolism | 10 | 2024 | 1893 | 1.000 |
Why?
|
Caloric Restriction | 10 | 2023 | 303 | 0.950 |
Why?
|
Apolipoproteins A | 4 | 2023 | 94 | 0.950 |
Why?
|
Fenofibrate | 3 | 2010 | 87 | 0.950 |
Why?
|
Apolipoprotein B-100 | 7 | 2023 | 157 | 0.930 |
Why?
|
Dyslipidemias | 9 | 2018 | 871 | 0.910 |
Why?
|
Myocardial Infarction | 43 | 2024 | 11509 | 0.900 |
Why?
|
Adiposity | 19 | 2023 | 1892 | 0.890 |
Why?
|
Middle Aged | 249 | 2024 | 223083 | 0.890 |
Why?
|
Lipoproteins, IDL | 7 | 2015 | 18 | 0.870 |
Why?
|
Humans | 438 | 2024 | 766117 | 0.850 |
Why?
|
Hypercholesterolemia | 13 | 2012 | 1148 | 0.850 |
Why?
|
Fatty Acids | 14 | 2020 | 1805 | 0.810 |
Why?
|
Apolipoprotein A-II | 4 | 2019 | 41 | 0.810 |
Why?
|
Cholesterol, VLDL | 9 | 2010 | 70 | 0.800 |
Why?
|
Male | 277 | 2024 | 363935 | 0.770 |
Why?
|
Fatty Acids, Omega-3 | 14 | 2016 | 1399 | 0.760 |
Why?
|
Female | 281 | 2024 | 396233 | 0.760 |
Why?
|
Dietary Fiber | 12 | 2021 | 767 | 0.760 |
Why?
|
Lipoprotein(a) | 7 | 2014 | 488 | 0.750 |
Why?
|
Pancreatitis, Chronic | 2 | 2014 | 282 | 0.740 |
Why?
|
Nutrition Policy | 5 | 2017 | 467 | 0.730 |
Why?
|
Lutein | 1 | 2021 | 122 | 0.730 |
Why?
|
Patient Compliance | 17 | 2019 | 2694 | 0.710 |
Why?
|
Adult | 204 | 2024 | 223139 | 0.700 |
Why?
|
Waist Circumference | 13 | 2024 | 934 | 0.670 |
Why?
|
Carotenoids | 5 | 2021 | 620 | 0.650 |
Why?
|
Benzimidazoles | 2 | 2014 | 862 | 0.630 |
Why?
|
Cross-Over Studies | 20 | 2023 | 2108 | 0.620 |
Why?
|
Body Composition | 13 | 2022 | 2441 | 0.600 |
Why?
|
Genotype | 38 | 2023 | 13028 | 0.590 |
Why?
|
Energy Intake | 20 | 2024 | 2141 | 0.590 |
Why?
|
Dementia | 2 | 2023 | 2741 | 0.590 |
Why?
|
Aged | 140 | 2024 | 171219 | 0.580 |
Why?
|
Diet, Vegetarian | 11 | 2019 | 181 | 0.580 |
Why?
|
Life Style | 16 | 2020 | 3928 | 0.570 |
Why?
|
Lipids | 28 | 2017 | 3316 | 0.570 |
Why?
|
Risk Factors | 94 | 2024 | 74857 | 0.560 |
Why?
|
Fatty Acids, Monounsaturated | 5 | 2008 | 190 | 0.560 |
Why?
|
Appetite | 5 | 2020 | 247 | 0.550 |
Why?
|
Isoflavones | 3 | 2006 | 139 | 0.550 |
Why?
|
Monocytes | 5 | 2019 | 2591 | 0.530 |
Why?
|
Soybean Proteins | 2 | 2006 | 55 | 0.520 |
Why?
|
Fatty Acids, Omega-6 | 2 | 2009 | 226 | 0.510 |
Why?
|
Polymorphism, Single Nucleotide | 28 | 2020 | 16040 | 0.510 |
Why?
|
Feeding Behavior | 11 | 2020 | 3209 | 0.500 |
Why?
|
Benzodiazepines | 1 | 2021 | 1136 | 0.500 |
Why?
|
Eggs | 8 | 2020 | 182 | 0.480 |
Why?
|
Liver | 11 | 2020 | 7559 | 0.480 |
Why?
|
Motivation | 2 | 2021 | 2019 | 0.470 |
Why?
|
Body Mass Index | 35 | 2024 | 13046 | 0.470 |
Why?
|
Blood Glucose | 16 | 2023 | 6421 | 0.470 |
Why?
|
Health Behavior | 4 | 2021 | 2649 | 0.460 |
Why?
|
Heart Diseases | 5 | 2014 | 2818 | 0.460 |
Why?
|
Coronary Artery Disease | 16 | 2024 | 6544 | 0.460 |
Why?
|
Lipoprotein Lipase | 4 | 2015 | 133 | 0.460 |
Why?
|
Double-Blind Method | 43 | 2024 | 12426 | 0.450 |
Why?
|
Nutritional Physiological Phenomena | 6 | 2006 | 357 | 0.440 |
Why?
|
Polymorphism, Genetic | 10 | 2010 | 4249 | 0.440 |
Why?
|
Kinetics | 13 | 2023 | 6273 | 0.440 |
Why?
|
Postmenopause | 7 | 2004 | 2517 | 0.440 |
Why?
|
Sodium Chloride, Dietary | 7 | 2022 | 303 | 0.430 |
Why?
|
Health Promotion | 4 | 2021 | 2209 | 0.430 |
Why?
|
Energy Metabolism | 7 | 2022 | 2894 | 0.420 |
Why?
|
Prospective Studies | 53 | 2024 | 54812 | 0.410 |
Why?
|
Heptanoic Acids | 3 | 2005 | 344 | 0.410 |
Why?
|
Estrogen Replacement Therapy | 10 | 2011 | 1206 | 0.400 |
Why?
|
Particle Size | 9 | 2021 | 1630 | 0.400 |
Why?
|
Fish Oils | 10 | 2002 | 483 | 0.390 |
Why?
|
Proteome | 2 | 2019 | 1896 | 0.390 |
Why?
|
Bile Acids and Salts | 3 | 2024 | 398 | 0.390 |
Why?
|
Basal Metabolism | 2 | 2013 | 163 | 0.390 |
Why?
|
Sodium | 7 | 2023 | 1591 | 0.380 |
Why?
|
Phospholipids | 7 | 2015 | 776 | 0.370 |
Why?
|
Proteomics | 3 | 2023 | 3907 | 0.370 |
Why?
|
Estradiol | 5 | 1999 | 1947 | 0.360 |
Why?
|
Receptor, Melatonin, MT2 | 4 | 2023 | 83 | 0.360 |
Why?
|
Phosphatidylcholine-Sterol O-Acyltransferase | 2 | 2021 | 33 | 0.350 |
Why?
|
Cardiovascular System | 4 | 2010 | 838 | 0.350 |
Why?
|
Protein Kinase C-alpha | 2 | 2006 | 112 | 0.330 |
Why?
|
Vegetables | 11 | 2021 | 1200 | 0.320 |
Why?
|
Sodium, Dietary | 8 | 2010 | 426 | 0.320 |
Why?
|
Cognition | 5 | 2023 | 7050 | 0.320 |
Why?
|
Methylamines | 3 | 2019 | 136 | 0.320 |
Why?
|
Randomized Controlled Trials as Topic | 31 | 2023 | 10380 | 0.320 |
Why?
|
Case-Control Studies | 25 | 2019 | 22228 | 0.320 |
Why?
|
Oligonucleotides | 1 | 2012 | 561 | 0.310 |
Why?
|
Food Analysis | 5 | 2017 | 103 | 0.310 |
Why?
|
Diabetic Nephropathies | 2 | 2013 | 968 | 0.310 |
Why?
|
Circadian Rhythm | 7 | 2018 | 2594 | 0.310 |
Why?
|
Albuminuria | 2 | 2011 | 659 | 0.310 |
Why?
|
Body Weight | 19 | 2023 | 4626 | 0.300 |
Why?
|
Pyrroles | 3 | 2005 | 1120 | 0.300 |
Why?
|
C-Reactive Protein | 8 | 2023 | 3853 | 0.300 |
Why?
|
Internationality | 1 | 2013 | 1007 | 0.300 |
Why?
|
Recurrence | 24 | 2024 | 8494 | 0.290 |
Why?
|
Insulin | 20 | 2022 | 6604 | 0.290 |
Why?
|
Health | 4 | 2010 | 397 | 0.290 |
Why?
|
Stroke | 10 | 2024 | 9748 | 0.290 |
Why?
|
Treatment Outcome | 48 | 2024 | 65219 | 0.290 |
Why?
|
Abdominal Fat | 4 | 2020 | 217 | 0.280 |
Why?
|
Risk Assessment | 29 | 2024 | 24276 | 0.280 |
Why?
|
Independent Living | 2 | 2021 | 583 | 0.280 |
Why?
|
Niacin | 6 | 2012 | 116 | 0.270 |
Why?
|
Pertussis Toxin | 1 | 2006 | 174 | 0.270 |
Why?
|
DNA Methylation | 5 | 2023 | 4425 | 0.270 |
Why?
|
Diabetic Angiopathies | 1 | 2011 | 805 | 0.270 |
Why?
|
Asparagine | 1 | 2006 | 120 | 0.270 |
Why?
|
United States | 45 | 2023 | 72920 | 0.260 |
Why?
|
Endothelium, Vascular | 4 | 2008 | 4423 | 0.260 |
Why?
|
Adiponectin | 3 | 2017 | 1120 | 0.260 |
Why?
|
Biological Transport | 5 | 2018 | 2080 | 0.260 |
Why?
|
Follow-Up Studies | 37 | 2023 | 39243 | 0.260 |
Why?
|
Amino Acids, Branched-Chain | 3 | 2020 | 266 | 0.260 |
Why?
|
Bone Density | 4 | 2021 | 3491 | 0.250 |
Why?
|
Magnesium | 6 | 1998 | 815 | 0.250 |
Why?
|
Fats, Unsaturated | 4 | 2022 | 21 | 0.250 |
Why?
|
Fatty Acids, Unsaturated | 8 | 2013 | 539 | 0.250 |
Why?
|
Chromatography, Affinity | 4 | 2012 | 521 | 0.250 |
Why?
|
Cholesterol, Dietary | 8 | 2005 | 224 | 0.250 |
Why?
|
Models, Psychological | 1 | 2009 | 823 | 0.250 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 2 | 2012 | 694 | 0.240 |
Why?
|
Risk | 20 | 2016 | 9599 | 0.240 |
Why?
|
Gonadal Steroid Hormones | 3 | 1995 | 706 | 0.240 |
Why?
|
Genetic Variation | 12 | 2019 | 6612 | 0.240 |
Why?
|
Phytoestrogens | 1 | 2005 | 59 | 0.240 |
Why?
|
Estrogens, Esterified (USP) | 1 | 2004 | 1 | 0.230 |
Why?
|
Methyltestosterone | 1 | 2004 | 19 | 0.230 |
Why?
|
Chylomicrons | 2 | 2023 | 26 | 0.230 |
Why?
|
Genetic Predisposition to Disease | 16 | 2019 | 18076 | 0.230 |
Why?
|
Dose-Response Relationship, Drug | 12 | 2010 | 10737 | 0.230 |
Why?
|
Diabetic Retinopathy | 1 | 2013 | 1294 | 0.230 |
Why?
|
Contraceptives, Oral | 3 | 1999 | 559 | 0.230 |
Why?
|
Aspartic Acid | 1 | 2006 | 575 | 0.220 |
Why?
|
Natriuretic Peptide, Brain | 3 | 2023 | 1735 | 0.220 |
Why?
|
Potassium | 4 | 1998 | 1312 | 0.220 |
Why?
|
Kidney Failure, Chronic | 4 | 2011 | 2504 | 0.220 |
Why?
|
Incidence | 19 | 2024 | 21513 | 0.210 |
Why?
|
Carnitine O-Palmitoyltransferase | 1 | 2023 | 81 | 0.210 |
Why?
|
Alleles | 13 | 2016 | 6892 | 0.210 |
Why?
|
Estrogens | 6 | 1999 | 1528 | 0.210 |
Why?
|
Diabetes Mellitus | 9 | 2016 | 5889 | 0.210 |
Why?
|
Amino Acids | 3 | 2018 | 1710 | 0.210 |
Why?
|
NF-kappa B | 4 | 2012 | 2495 | 0.210 |
Why?
|
Risk Reduction Behavior | 6 | 2014 | 1121 | 0.210 |
Why?
|
Neuropeptide Y | 2 | 2015 | 194 | 0.210 |
Why?
|
Linear Models | 13 | 2019 | 5873 | 0.210 |
Why?
|
Hypolipoproteinemias | 1 | 2002 | 2 | 0.210 |
Why?
|
Receptors, Fc | 1 | 2006 | 537 | 0.210 |
Why?
|
Body Fat Distribution | 3 | 2016 | 246 | 0.210 |
Why?
|
Phytotherapy | 1 | 2005 | 297 | 0.210 |
Why?
|
Uric Acid | 2 | 2021 | 809 | 0.200 |
Why?
|
Carnitine | 3 | 2019 | 253 | 0.200 |
Why?
|
Marital Status | 2 | 2014 | 426 | 0.200 |
Why?
|
Fasting | 8 | 2018 | 1606 | 0.200 |
Why?
|
Editorial Policies | 1 | 2007 | 458 | 0.200 |
Why?
|
Conflict of Interest | 1 | 2007 | 556 | 0.200 |
Why?
|
GTP-Binding Proteins | 1 | 2006 | 945 | 0.200 |
Why?
|
Fruit | 10 | 2010 | 1167 | 0.200 |
Why?
|
Ultracentrifugation | 3 | 2012 | 155 | 0.200 |
Why?
|
alpha-Linolenic Acid | 2 | 2013 | 145 | 0.200 |
Why?
|
Cause of Death | 6 | 2015 | 3715 | 0.200 |
Why?
|
Choline | 3 | 2019 | 511 | 0.190 |
Why?
|
Butadienes | 1 | 2002 | 107 | 0.190 |
Why?
|
Adipose Tissue | 9 | 2017 | 3315 | 0.190 |
Why?
|
Apolipoprotein B-48 | 3 | 2006 | 20 | 0.190 |
Why?
|
Cohort Studies | 24 | 2021 | 41684 | 0.190 |
Why?
|
Lipase | 3 | 2015 | 320 | 0.190 |
Why?
|
Insulin Receptor Substrate Proteins | 3 | 2013 | 558 | 0.190 |
Why?
|
Diabetes Complications | 3 | 2003 | 1318 | 0.190 |
Why?
|
Azetidines | 1 | 2002 | 151 | 0.190 |
Why?
|
Eicosapentaenoic Acid | 7 | 2016 | 565 | 0.190 |
Why?
|
Peptide Fragments | 5 | 2023 | 5126 | 0.190 |
Why?
|
Kidney Diseases | 7 | 2011 | 2100 | 0.190 |
Why?
|
Angina, Unstable | 2 | 2005 | 893 | 0.180 |
Why?
|
Endothelial Cells | 3 | 2012 | 3586 | 0.180 |
Why?
|
Fatty Acids, Volatile | 1 | 2021 | 100 | 0.180 |
Why?
|
Peroxisome Proliferator-Activated Receptors | 1 | 2020 | 61 | 0.180 |
Why?
|
Drug Therapy, Combination | 8 | 2010 | 6309 | 0.170 |
Why?
|
Salivary alpha-Amylases | 1 | 2020 | 16 | 0.170 |
Why?
|
Proportional Hazards Models | 16 | 2019 | 12529 | 0.170 |
Why?
|
Nutrition Therapy | 1 | 2021 | 101 | 0.170 |
Why?
|
Troponin I | 2 | 2023 | 656 | 0.170 |
Why?
|
Kidney | 3 | 2011 | 7072 | 0.170 |
Why?
|
Simvastatin | 1 | 2002 | 345 | 0.170 |
Why?
|
Time Factors | 25 | 2018 | 40108 | 0.170 |
Why?
|
Cardiology | 3 | 2019 | 1696 | 0.170 |
Why?
|
Phospholipid Transfer Proteins | 1 | 2021 | 90 | 0.170 |
Why?
|
Glomerular Filtration Rate | 6 | 2019 | 2232 | 0.170 |
Why?
|
Esters | 1 | 2021 | 213 | 0.170 |
Why?
|
Carbohydrates | 1 | 2022 | 387 | 0.170 |
Why?
|
Carcinogens | 1 | 2002 | 451 | 0.170 |
Why?
|
Obesity, Abdominal | 3 | 2022 | 371 | 0.160 |
Why?
|
Sulfhydryl Compounds | 1 | 2021 | 296 | 0.160 |
Why?
|
Protein Binding | 4 | 2018 | 9301 | 0.160 |
Why?
|
Infusions, Intravenous | 4 | 2024 | 2227 | 0.160 |
Why?
|
Nutritional Status | 4 | 2021 | 1620 | 0.160 |
Why?
|
Morbidity | 1 | 2005 | 1753 | 0.160 |
Why?
|
Glycoproteins | 4 | 2005 | 2196 | 0.160 |
Why?
|
Clusterin | 1 | 2019 | 72 | 0.160 |
Why?
|
Meat | 4 | 2023 | 588 | 0.160 |
Why?
|
Models, Biological | 6 | 2021 | 9445 | 0.160 |
Why?
|
Carrier Proteins | 6 | 2022 | 4910 | 0.160 |
Why?
|
Denmark | 2 | 2018 | 774 | 0.150 |
Why?
|
Regression Analysis | 12 | 2017 | 6324 | 0.150 |
Why?
|
Computers | 2 | 2012 | 588 | 0.150 |
Why?
|
Practice Guidelines as Topic | 6 | 2021 | 7424 | 0.150 |
Why?
|
Docosahexaenoic Acids | 7 | 2016 | 916 | 0.150 |
Why?
|
MicroRNAs | 3 | 2024 | 3787 | 0.150 |
Why?
|
Dairy Products | 6 | 2010 | 490 | 0.150 |
Why?
|
Sodium Chloride | 2 | 2017 | 578 | 0.150 |
Why?
|
Amides | 1 | 2021 | 451 | 0.150 |
Why?
|
Multicenter Studies as Topic | 5 | 2020 | 1729 | 0.150 |
Why?
|
Odds Ratio | 8 | 2014 | 9657 | 0.150 |
Why?
|
Eating | 2 | 2023 | 1538 | 0.150 |
Why?
|
Glucose Tolerance Test | 1 | 2021 | 1180 | 0.150 |
Why?
|
Potassium Chloride | 2 | 1995 | 227 | 0.150 |
Why?
|
Mass Spectrometry | 3 | 2021 | 2195 | 0.150 |
Why?
|
Actigraphy | 1 | 2022 | 526 | 0.150 |
Why?
|
Antioxidants | 3 | 2018 | 1671 | 0.150 |
Why?
|
Lactase | 1 | 2018 | 72 | 0.150 |
Why?
|
Pancreatic alpha-Amylases | 1 | 2017 | 7 | 0.140 |
Why?
|
Cooking | 3 | 2017 | 327 | 0.140 |
Why?
|
Lactic Acid | 2 | 2020 | 1137 | 0.140 |
Why?
|
Glycerolphosphate Dehydrogenase | 1 | 2017 | 40 | 0.140 |
Why?
|
DNA | 3 | 2012 | 7193 | 0.140 |
Why?
|
Toll-Like Receptor 2 | 2 | 2010 | 347 | 0.140 |
Why?
|
Secondary Prevention | 6 | 2024 | 1470 | 0.140 |
Why?
|
Arteriosclerosis | 5 | 1998 | 1055 | 0.140 |
Why?
|
Cell Adhesion | 4 | 2012 | 3089 | 0.140 |
Why?
|
Nutritive Value | 2 | 2019 | 350 | 0.140 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2018 | 175 | 0.140 |
Why?
|
Genetic Association Studies | 5 | 2019 | 2744 | 0.140 |
Why?
|
Hemostasis | 2 | 2018 | 467 | 0.140 |
Why?
|
Amino Acids, Aromatic | 2 | 2016 | 36 | 0.140 |
Why?
|
Glucose | 5 | 2023 | 4335 | 0.140 |
Why?
|
Rest | 2 | 2012 | 940 | 0.140 |
Why?
|
Protein Stability | 1 | 2018 | 576 | 0.140 |
Why?
|
Food, Fortified | 2 | 1995 | 189 | 0.130 |
Why?
|
Deoxyglucose | 1 | 2017 | 322 | 0.130 |
Why?
|
Receptor, Melanocortin, Type 4 | 1 | 2017 | 132 | 0.130 |
Why?
|
Clinical Trials as Topic | 14 | 2005 | 8038 | 0.130 |
Why?
|
High-Density Lipoproteins, Pre-beta | 1 | 2015 | 6 | 0.130 |
Why?
|
Periodicals as Topic | 1 | 2007 | 1463 | 0.130 |
Why?
|
Taurine | 1 | 2016 | 91 | 0.130 |
Why?
|
Aged, 80 and over | 20 | 2023 | 59515 | 0.130 |
Why?
|
Health Education | 2 | 2021 | 1060 | 0.130 |
Why?
|
Antigens, CD | 1 | 2006 | 4025 | 0.130 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2019 | 3801 | 0.130 |
Why?
|
Vitamin D | 3 | 2021 | 3272 | 0.130 |
Why?
|
Reference Values | 7 | 2008 | 4909 | 0.120 |
Why?
|
Satiation | 2 | 2009 | 84 | 0.120 |
Why?
|
Thyroid Hormones | 2 | 2017 | 408 | 0.120 |
Why?
|
Indoles | 1 | 2003 | 1833 | 0.120 |
Why?
|
Margarine | 1 | 1995 | 17 | 0.120 |
Why?
|
Prognosis | 13 | 2022 | 29912 | 0.120 |
Why?
|
Genome-Wide Association Study | 10 | 2023 | 12803 | 0.120 |
Why?
|
Predictive Value of Tests | 8 | 2018 | 15403 | 0.120 |
Why?
|
Postprandial Period | 3 | 2007 | 320 | 0.120 |
Why?
|
Quinolines | 2 | 2012 | 769 | 0.120 |
Why?
|
Intestinal Mucosa | 1 | 2006 | 3048 | 0.120 |
Why?
|
Administration, Oral | 7 | 2004 | 4016 | 0.120 |
Why?
|
Proteins | 3 | 2015 | 5995 | 0.120 |
Why?
|
Czechoslovakia | 1 | 2014 | 6 | 0.120 |
Why?
|
Hyperglycemia | 2 | 2017 | 1389 | 0.120 |
Why?
|
Subtilisins | 1 | 2014 | 80 | 0.120 |
Why?
|
Vasomotor System | 1 | 1995 | 208 | 0.120 |
Why?
|
Multivariate Analysis | 10 | 2019 | 12061 | 0.120 |
Why?
|
Metabolic Networks and Pathways | 1 | 2019 | 798 | 0.120 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2015 | 355 | 0.110 |
Why?
|
Chemistry | 1 | 2014 | 325 | 0.110 |
Why?
|
Vascular Diseases | 2 | 2015 | 1161 | 0.110 |
Why?
|
Plant Oils | 5 | 2010 | 199 | 0.110 |
Why?
|
Serum Amyloid P-Component | 1 | 2014 | 46 | 0.110 |
Why?
|
Cryptochromes | 1 | 2013 | 49 | 0.110 |
Why?
|
Receptor, Melatonin, MT1 | 1 | 2013 | 31 | 0.110 |
Why?
|
Blood Vessels | 1 | 2019 | 1113 | 0.110 |
Why?
|
Logistic Models | 8 | 2010 | 13273 | 0.110 |
Why?
|
Deuterium | 2 | 2021 | 105 | 0.110 |
Why?
|
Alzheimer Disease | 3 | 2021 | 8724 | 0.110 |
Why?
|
Coffee | 2 | 2017 | 593 | 0.110 |
Why?
|
Models, Cardiovascular | 1 | 2019 | 978 | 0.110 |
Why?
|
Calcium | 2 | 1998 | 5770 | 0.110 |
Why?
|
Genetic Determinism | 1 | 2013 | 11 | 0.110 |
Why?
|
Peripheral Vascular Diseases | 1 | 1996 | 489 | 0.110 |
Why?
|
Cell Line | 6 | 2009 | 15546 | 0.110 |
Why?
|
Cholesterol Esters | 3 | 1995 | 68 | 0.110 |
Why?
|
Menopause | 7 | 1993 | 1659 | 0.100 |
Why?
|
Pharmacogenetics | 2 | 2021 | 682 | 0.100 |
Why?
|
Placebos | 6 | 2011 | 1659 | 0.100 |
Why?
|
Coronary Angiography | 7 | 1995 | 4498 | 0.100 |
Why?
|
Fibric Acids | 1 | 2012 | 27 | 0.100 |
Why?
|
Exercise | 7 | 2022 | 5939 | 0.100 |
Why?
|
Psychiatry | 1 | 2005 | 1715 | 0.100 |
Why?
|
Absorptiometry, Photon | 5 | 2019 | 1707 | 0.100 |
Why?
|
Metabolome | 1 | 2019 | 1005 | 0.100 |
Why?
|
Behavior | 2 | 2019 | 537 | 0.100 |
Why?
|
Placebo Effect | 1 | 2016 | 515 | 0.100 |
Why?
|
Leucine | 2 | 2010 | 547 | 0.100 |
Why?
|
Anthropometry | 1 | 2017 | 1339 | 0.100 |
Why?
|
Neurodegenerative Diseases | 1 | 2021 | 1088 | 0.100 |
Why?
|
Patient Identification Systems | 1 | 2012 | 75 | 0.100 |
Why?
|
Transcription Factor 7-Like 2 Protein | 1 | 2012 | 152 | 0.100 |
Why?
|
Primary Prevention | 3 | 2015 | 1187 | 0.100 |
Why?
|
Calcinosis | 1 | 2021 | 1475 | 0.100 |
Why?
|
Receptors, Gastrointestinal Hormone | 1 | 2012 | 45 | 0.100 |
Why?
|
Probability | 4 | 2008 | 2475 | 0.100 |
Why?
|
Research Design | 6 | 2005 | 6206 | 0.100 |
Why?
|
Behavior Therapy | 2 | 2014 | 886 | 0.090 |
Why?
|
Animals | 27 | 2019 | 168800 | 0.090 |
Why?
|
Cerebrovascular Disorders | 4 | 2012 | 1478 | 0.090 |
Why?
|
Carotid Artery Diseases | 1 | 2018 | 872 | 0.090 |
Why?
|
Hydroxymethylglutaryl CoA Reductases | 1 | 2011 | 64 | 0.090 |
Why?
|
Los Angeles | 1 | 2011 | 244 | 0.090 |
Why?
|
Diet Records | 5 | 2017 | 425 | 0.090 |
Why?
|
Aortic Valve | 1 | 2021 | 1964 | 0.090 |
Why?
|
Blood Pressure Determination | 4 | 2019 | 646 | 0.090 |
Why?
|
Renin | 1 | 2013 | 647 | 0.090 |
Why?
|
Fibroblast Growth Factors | 1 | 2016 | 871 | 0.090 |
Why?
|
Louisiana | 3 | 2016 | 104 | 0.090 |
Why?
|
Antigens, Neoplasm | 1 | 1998 | 1996 | 0.090 |
Why?
|
Heart Failure | 5 | 2022 | 11837 | 0.090 |
Why?
|
Diet Fads | 2 | 2008 | 14 | 0.090 |
Why?
|
Atrial Fibrillation | 3 | 2014 | 5185 | 0.080 |
Why?
|
Inflammation Mediators | 1 | 1999 | 1890 | 0.080 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2019 | 2306 | 0.080 |
Why?
|
Socioeconomic Factors | 1 | 2024 | 7843 | 0.080 |
Why?
|
Triticum | 1 | 1990 | 92 | 0.080 |
Why?
|
Diet Surveys | 6 | 2015 | 1159 | 0.080 |
Why?
|
Exercise Therapy | 2 | 2014 | 938 | 0.080 |
Why?
|
Societies, Medical | 2 | 2019 | 3955 | 0.080 |
Why?
|
Acute Coronary Syndrome | 2 | 2013 | 2185 | 0.080 |
Why?
|
Microvessels | 1 | 2013 | 590 | 0.080 |
Why?
|
Prazosin | 1 | 1989 | 95 | 0.080 |
Why?
|
Monitoring, Physiologic | 2 | 2017 | 1794 | 0.080 |
Why?
|
Analysis of Variance | 6 | 2008 | 6208 | 0.080 |
Why?
|
Scavenger Receptors, Class B | 1 | 2009 | 85 | 0.080 |
Why?
|
Insulin-Secreting Cells | 1 | 2016 | 899 | 0.080 |
Why?
|
Trans Fatty Acids | 1 | 2010 | 155 | 0.080 |
Why?
|
Food Preferences | 1 | 2012 | 397 | 0.080 |
Why?
|
Gene Frequency | 3 | 2014 | 3623 | 0.080 |
Why?
|
Seafood | 1 | 2012 | 395 | 0.080 |
Why?
|
Feedback | 1 | 2012 | 796 | 0.080 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 4 | 2014 | 254 | 0.080 |
Why?
|
Health Status | 1 | 2021 | 4086 | 0.080 |
Why?
|
Phenylalanine | 1 | 2010 | 367 | 0.080 |
Why?
|
Diet, Atherogenic | 2 | 2005 | 92 | 0.080 |
Why?
|
Menu Planning | 1 | 2008 | 29 | 0.080 |
Why?
|
Aortic Valve Stenosis | 1 | 2021 | 2022 | 0.080 |
Why?
|
Inflammation | 4 | 2023 | 10860 | 0.070 |
Why?
|
Comorbidity | 6 | 2005 | 10579 | 0.070 |
Why?
|
History, 21st Century | 1 | 2014 | 1574 | 0.070 |
Why?
|
Chemokine CCL2 | 1 | 2010 | 602 | 0.070 |
Why?
|
Cross-Sectional Studies | 9 | 2021 | 26290 | 0.070 |
Why?
|
Heterozygote | 5 | 2015 | 2796 | 0.070 |
Why?
|
Sex Factors | 10 | 2017 | 10614 | 0.070 |
Why?
|
Europe | 4 | 2020 | 3430 | 0.070 |
Why?
|
Models, Theoretical | 1 | 2019 | 3561 | 0.070 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2009 | 415 | 0.070 |
Why?
|
Dietary Sucrose | 1 | 2009 | 241 | 0.070 |
Why?
|
PPAR alpha | 1 | 2008 | 177 | 0.070 |
Why?
|
Aorta | 3 | 2012 | 2040 | 0.070 |
Why?
|
Linoleic Acids | 1 | 1987 | 39 | 0.070 |
Why?
|
Osmolar Concentration | 2 | 1999 | 655 | 0.070 |
Why?
|
Severity of Illness Index | 5 | 2016 | 15882 | 0.070 |
Why?
|
Disease Progression | 7 | 2020 | 13616 | 0.070 |
Why?
|
Arginine | 2 | 2008 | 931 | 0.070 |
Why?
|
Propranolol | 1 | 1989 | 494 | 0.070 |
Why?
|
Norbornanes | 1 | 2006 | 10 | 0.070 |
Why?
|
Phosphatidylinositol Diacylglycerol-Lyase | 1 | 2006 | 19 | 0.070 |
Why?
|
Ghrelin | 1 | 2009 | 255 | 0.070 |
Why?
|
Thiocarbamates | 1 | 2006 | 30 | 0.070 |
Why?
|
Macrophages | 2 | 1996 | 5776 | 0.070 |
Why?
|
Oleic Acids | 1 | 1987 | 70 | 0.070 |
Why?
|
Patient Care Planning | 1 | 2012 | 903 | 0.070 |
Why?
|
Thiones | 1 | 2006 | 50 | 0.070 |
Why?
|
Blood Viscosity | 1 | 1987 | 125 | 0.070 |
Why?
|
Factor Analysis, Statistical | 1 | 2009 | 1001 | 0.070 |
Why?
|
Scotland | 1 | 2006 | 142 | 0.070 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2008 | 325 | 0.070 |
Why?
|
Adrenergic alpha-Antagonists | 1 | 1987 | 171 | 0.070 |
Why?
|
Diet, Protein-Restricted | 2 | 2018 | 73 | 0.070 |
Why?
|
Alkaline Phosphatase | 1 | 2009 | 855 | 0.070 |
Why?
|
Forearm | 1 | 1989 | 426 | 0.070 |
Why?
|
Sympatholytics | 1 | 1986 | 82 | 0.070 |
Why?
|
Biology | 2 | 2023 | 293 | 0.060 |
Why?
|
Electrolytes | 1 | 1987 | 279 | 0.060 |
Why?
|
History, 20th Century | 1 | 2014 | 2762 | 0.060 |
Why?
|
Schizophrenia | 1 | 2005 | 6975 | 0.060 |
Why?
|
Leptin | 2 | 2017 | 1596 | 0.060 |
Why?
|
Longitudinal Studies | 6 | 2014 | 14747 | 0.060 |
Why?
|
Proteinuria | 2 | 2006 | 606 | 0.060 |
Why?
|
I-kappa B Proteins | 1 | 2006 | 210 | 0.060 |
Why?
|
Aryldialkylphosphatase | 1 | 2005 | 64 | 0.060 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2006 | 213 | 0.060 |
Why?
|
Eicosanoic Acids | 2 | 2015 | 15 | 0.060 |
Why?
|
Gene Expression Regulation | 5 | 2017 | 11906 | 0.060 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2009 | 566 | 0.060 |
Why?
|
Young Adult | 3 | 2018 | 59868 | 0.060 |
Why?
|
Leukocytes, Mononuclear | 1 | 2012 | 1852 | 0.060 |
Why?
|
Calcium Carbonate | 2 | 1995 | 62 | 0.060 |
Why?
|
Dietary Supplements | 3 | 2021 | 3427 | 0.060 |
Why?
|
Protein Kinase C | 2 | 2008 | 1205 | 0.060 |
Why?
|
Administration, Cutaneous | 3 | 1994 | 712 | 0.060 |
Why?
|
Matrix Metalloproteinases | 1 | 2008 | 392 | 0.060 |
Why?
|
Stearic Acids | 2 | 2015 | 56 | 0.060 |
Why?
|
Cells, Cultured | 5 | 2021 | 18967 | 0.060 |
Why?
|
beta Carotene | 4 | 1999 | 523 | 0.060 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2006 | 234 | 0.060 |
Why?
|
Salpingostomy | 1 | 2004 | 8 | 0.060 |
Why?
|
Bacterial Proteins | 1 | 2018 | 3830 | 0.060 |
Why?
|
Fishes | 2 | 2002 | 607 | 0.060 |
Why?
|
Chicago | 2 | 2015 | 255 | 0.060 |
Why?
|
Erythrocytes | 2 | 2020 | 2394 | 0.060 |
Why?
|
Palmitic Acid | 2 | 2015 | 147 | 0.060 |
Why?
|
Survival Rate | 5 | 2010 | 12827 | 0.060 |
Why?
|
Cognition Disorders | 2 | 2015 | 3966 | 0.060 |
Why?
|
Prevalence | 5 | 2013 | 15827 | 0.060 |
Why?
|
Antihypertensive Agents | 3 | 2014 | 2028 | 0.060 |
Why?
|
Biomedical Research | 1 | 2019 | 3458 | 0.060 |
Why?
|
Food Handling | 1 | 2024 | 158 | 0.060 |
Why?
|
Diet Therapy | 1 | 2005 | 149 | 0.050 |
Why?
|
Promoter Regions, Genetic | 2 | 2012 | 5784 | 0.050 |
Why?
|
Plasma Membrane Calcium-Transporting ATPases | 1 | 2023 | 17 | 0.050 |
Why?
|
Adipocytes | 1 | 2010 | 1196 | 0.050 |
Why?
|
Lactones | 1 | 2006 | 316 | 0.050 |
Why?
|
Massachusetts | 2 | 2018 | 8882 | 0.050 |
Why?
|
Caseins | 1 | 1983 | 105 | 0.050 |
Why?
|
Glycochenodeoxycholic Acid | 1 | 2022 | 4 | 0.050 |
Why?
|
Australia | 2 | 2002 | 1260 | 0.050 |
Why?
|
Atmospheric Pressure | 1 | 2002 | 48 | 0.050 |
Why?
|
Disease Management | 1 | 2013 | 2531 | 0.050 |
Why?
|
Blood Proteins | 1 | 2008 | 1186 | 0.050 |
Why?
|
Progestins | 2 | 1995 | 300 | 0.050 |
Why?
|
Taurochenodeoxycholic Acid | 1 | 2022 | 35 | 0.050 |
Why?
|
Sleep | 2 | 2022 | 4816 | 0.050 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2006 | 1131 | 0.050 |
Why?
|
Pregnancy | 2 | 2014 | 30233 | 0.050 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2002 | 168 | 0.050 |
Why?
|
Coronary Vessels | 3 | 2004 | 3094 | 0.050 |
Why?
|
Renal Insufficiency | 2 | 2005 | 810 | 0.050 |
Why?
|
Fast Foods | 1 | 2024 | 220 | 0.050 |
Why?
|
Antigen-Presenting Cells | 1 | 2005 | 960 | 0.050 |
Why?
|
Phosphates | 1 | 2005 | 763 | 0.050 |
Why?
|
Estrogens, Conjugated (USP) | 2 | 1994 | 274 | 0.050 |
Why?
|
Ovariectomy | 1 | 2004 | 612 | 0.050 |
Why?
|
Alcohol Drinking | 7 | 2012 | 4044 | 0.050 |
Why?
|
Patient Dropouts | 1 | 2004 | 411 | 0.050 |
Why?
|
Food Industry | 1 | 2022 | 68 | 0.050 |
Why?
|
Muscular Diseases | 2 | 2002 | 551 | 0.050 |
Why?
|
Drug Evaluation | 2 | 2004 | 642 | 0.050 |
Why?
|
New Zealand | 1 | 2002 | 360 | 0.050 |
Why?
|
Mutation, Missense | 1 | 2010 | 2590 | 0.050 |
Why?
|
Asia | 2 | 2020 | 630 | 0.050 |
Why?
|
Gases | 1 | 2002 | 205 | 0.050 |
Why?
|
Angiotensinogen | 1 | 2001 | 161 | 0.050 |
Why?
|
Adrenergic beta-Antagonists | 1 | 1987 | 1239 | 0.050 |
Why?
|
Counseling | 1 | 2009 | 1553 | 0.050 |
Why?
|
Autoantigens | 1 | 2005 | 886 | 0.040 |
Why?
|
Temperature | 2 | 2002 | 2227 | 0.040 |
Why?
|
Constriction, Pathologic | 2 | 1995 | 1102 | 0.040 |
Why?
|
Enzyme Activation | 1 | 2006 | 3584 | 0.040 |
Why?
|
Survival Analysis | 5 | 2015 | 10087 | 0.040 |
Why?
|
Polymerase Chain Reaction | 1 | 2010 | 6059 | 0.040 |
Why?
|
Alcohol Dehydrogenase | 1 | 2001 | 113 | 0.040 |
Why?
|
Interleukin-6 | 1 | 2010 | 3227 | 0.040 |
Why?
|
Body Constitution | 1 | 2000 | 272 | 0.040 |
Why?
|
Angina Pectoris | 1 | 2004 | 957 | 0.040 |
Why?
|
Mice | 9 | 2019 | 81839 | 0.040 |
Why?
|
Age Factors | 9 | 2013 | 18386 | 0.040 |
Why?
|
DNA-Binding Proteins | 1 | 2017 | 9601 | 0.040 |
Why?
|
Antigen Presentation | 1 | 2005 | 1250 | 0.040 |
Why?
|
Netherlands | 1 | 2005 | 2277 | 0.040 |
Why?
|
Drug Synergism | 1 | 2004 | 1754 | 0.040 |
Why?
|
Guidelines as Topic | 1 | 2006 | 1394 | 0.040 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2001 | 324 | 0.040 |
Why?
|
Angioplasty, Balloon, Coronary | 4 | 2004 | 1721 | 0.040 |
Why?
|
Smoking | 5 | 2012 | 9082 | 0.040 |
Why?
|
Random Allocation | 4 | 1989 | 2395 | 0.040 |
Why?
|
Nutritional Sciences | 1 | 2001 | 148 | 0.040 |
Why?
|
Costa Rica | 2 | 2010 | 187 | 0.040 |
Why?
|
Wounds, Stab | 1 | 1979 | 72 | 0.040 |
Why?
|
Resins, Synthetic | 1 | 1999 | 24 | 0.040 |
Why?
|
Chromatography, Liquid | 1 | 2003 | 992 | 0.040 |
Why?
|
Blood Chemical Analysis | 1 | 2021 | 434 | 0.040 |
Why?
|
Kidney Function Tests | 3 | 2005 | 684 | 0.040 |
Why?
|
Disease Susceptibility | 1 | 2006 | 1790 | 0.040 |
Why?
|
Acinetobacter Infections | 1 | 1979 | 74 | 0.040 |
Why?
|
Calcium, Dietary | 3 | 1998 | 527 | 0.040 |
Why?
|
Protein Precursors | 2 | 2020 | 1133 | 0.040 |
Why?
|
Weight Gain | 2 | 2022 | 2356 | 0.040 |
Why?
|
Hysterectomy | 1 | 2004 | 864 | 0.040 |
Why?
|
Canada | 2 | 2002 | 2120 | 0.040 |
Why?
|
Drug Administration Schedule | 3 | 2008 | 4853 | 0.040 |
Why?
|
Molecular Weight | 1 | 2021 | 2161 | 0.040 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2001 | 577 | 0.040 |
Why?
|
Treatment Failure | 1 | 2005 | 2653 | 0.040 |
Why?
|
Homeostasis | 3 | 2014 | 3338 | 0.040 |
Why?
|
Patient Selection | 4 | 2011 | 4249 | 0.040 |
Why?
|
Boston | 4 | 2016 | 9335 | 0.040 |
Why?
|
Intra-Abdominal Fat | 2 | 2015 | 624 | 0.040 |
Why?
|
Least-Squares Analysis | 1 | 1999 | 368 | 0.040 |
Why?
|
Chronic Disease | 3 | 2008 | 9354 | 0.040 |
Why?
|
Sex Characteristics | 2 | 2015 | 2646 | 0.040 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 1999 | 187 | 0.040 |
Why?
|
Troponin T | 1 | 2023 | 785 | 0.040 |
Why?
|
Endpoint Determination | 1 | 2000 | 591 | 0.040 |
Why?
|
Vitamin D-Binding Protein | 1 | 2018 | 129 | 0.040 |
Why?
|
Transcription Factors | 1 | 2017 | 12130 | 0.040 |
Why?
|
Bifidobacterium | 1 | 2018 | 99 | 0.040 |
Why?
|
Molecular Epidemiology | 1 | 2019 | 472 | 0.040 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 1 | 2018 | 172 | 0.040 |
Why?
|
Aspirin | 4 | 2004 | 3135 | 0.040 |
Why?
|
Drug Interactions | 1 | 2002 | 1419 | 0.030 |
Why?
|
Quality-Adjusted Life Years | 1 | 2024 | 1740 | 0.030 |
Why?
|
Aging | 2 | 2015 | 8723 | 0.030 |
Why?
|
Intestines | 1 | 2006 | 1904 | 0.030 |
Why?
|
Nuts | 1 | 1999 | 265 | 0.030 |
Why?
|
Life Expectancy | 1 | 2024 | 1248 | 0.030 |
Why?
|
Sensitivity and Specificity | 5 | 2003 | 14645 | 0.030 |
Why?
|
Communicable Diseases | 1 | 2005 | 873 | 0.030 |
Why?
|
Brain | 1 | 2023 | 27177 | 0.030 |
Why?
|
Autoantibodies | 1 | 2005 | 2114 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 1 | 1993 | 8924 | 0.030 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2011 | 3445 | 0.030 |
Why?
|
Combined Modality Therapy | 3 | 2014 | 8525 | 0.030 |
Why?
|
International Cooperation | 2 | 2014 | 1433 | 0.030 |
Why?
|
Health Personnel | 2 | 2006 | 3387 | 0.030 |
Why?
|
Ultrasonography, Interventional | 1 | 2004 | 1520 | 0.030 |
Why?
|
Microscopy, Electron | 1 | 1999 | 2543 | 0.030 |
Why?
|
Butter | 1 | 1995 | 22 | 0.030 |
Why?
|
Endocarditis, Bacterial | 1 | 1979 | 434 | 0.030 |
Why?
|
Lipoproteins, HDL2 | 1 | 1994 | 2 | 0.030 |
Why?
|
Lipoproteins, HDL3 | 1 | 1994 | 2 | 0.030 |
Why?
|
Down-Regulation | 2 | 2016 | 2927 | 0.030 |
Why?
|
Intracranial Arteriosclerosis | 1 | 1996 | 138 | 0.030 |
Why?
|
Cholestyramine Resin | 1 | 1994 | 25 | 0.030 |
Why?
|
Gemfibrozil | 1 | 1994 | 30 | 0.030 |
Why?
|
Patient Satisfaction | 1 | 2007 | 3477 | 0.030 |
Why?
|
Adipose Tissue, White | 1 | 2018 | 371 | 0.030 |
Why?
|
Birth Weight | 1 | 2023 | 2122 | 0.030 |
Why?
|
Systole | 3 | 2001 | 935 | 0.030 |
Why?
|
Subcutaneous Fat, Abdominal | 1 | 2015 | 91 | 0.030 |
Why?
|
Cystatin C | 1 | 2016 | 272 | 0.030 |
Why?
|
Congresses as Topic | 1 | 2019 | 811 | 0.030 |
Why?
|
Motor Activity | 2 | 2014 | 2711 | 0.030 |
Why?
|
Coronary Artery Bypass | 3 | 1999 | 2188 | 0.030 |
Why?
|
Nutrition Assessment | 1 | 2017 | 738 | 0.030 |
Why?
|
Oxidative Stress | 1 | 2005 | 3140 | 0.030 |
Why?
|
Receptors, LDL | 2 | 2005 | 492 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 1 | 2024 | 6506 | 0.030 |
Why?
|
Patient Acceptance of Health Care | 1 | 2007 | 3230 | 0.030 |
Why?
|
Self-Help Groups | 1 | 2014 | 194 | 0.030 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2004 | 2768 | 0.030 |
Why?
|
Genetic Markers | 1 | 2019 | 2603 | 0.030 |
Why?
|
Reproducibility of Results | 4 | 2017 | 20137 | 0.030 |
Why?
|
Smoking Cessation | 1 | 2005 | 2084 | 0.030 |
Why?
|
Ventricular Function, Left | 2 | 2022 | 3930 | 0.030 |
Why?
|
Psychological Tests | 1 | 2015 | 642 | 0.030 |
Why?
|
Intermittent Claudication | 1 | 1995 | 305 | 0.030 |
Why?
|
Executive Function | 1 | 2021 | 1395 | 0.030 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2017 | 1167 | 0.030 |
Why?
|
Tanzania | 1 | 2017 | 1407 | 0.030 |
Why?
|
Follicle Stimulating Hormone | 1 | 1994 | 731 | 0.020 |
Why?
|
Disease Models, Animal | 3 | 2019 | 18321 | 0.020 |
Why?
|
Femur | 1 | 2018 | 1309 | 0.020 |
Why?
|
Fatty Acid Desaturases | 1 | 2012 | 102 | 0.020 |
Why?
|
Phenotype | 1 | 2010 | 16716 | 0.020 |
Why?
|
Meta-Analysis as Topic | 2 | 2011 | 1366 | 0.020 |
Why?
|
Antibodies, Monoclonal | 2 | 2001 | 9237 | 0.020 |
Why?
|
Stroke Volume | 2 | 2022 | 5595 | 0.020 |
Why?
|
Mortality | 2 | 2015 | 2911 | 0.020 |
Why?
|
Tuna | 1 | 1991 | 18 | 0.020 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2013 | 327 | 0.020 |
Why?
|
Food Labeling | 1 | 1993 | 181 | 0.020 |
Why?
|
Belgium | 1 | 2011 | 119 | 0.020 |
Why?
|
Mental Recall | 1 | 2017 | 1217 | 0.020 |
Why?
|
Prostatic Neoplasms | 3 | 1999 | 11094 | 0.020 |
Why?
|
Discriminant Analysis | 1 | 2011 | 222 | 0.020 |
Why?
|
Antibodies | 1 | 1999 | 2415 | 0.020 |
Why?
|
Myocarditis | 1 | 1998 | 803 | 0.020 |
Why?
|
Hydrogenation | 1 | 2010 | 20 | 0.020 |
Why?
|
Adolescent | 7 | 2012 | 88819 | 0.020 |
Why?
|
Statistics as Topic | 2 | 1998 | 2351 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2017 | 2718 | 0.020 |
Why?
|
Health Surveys | 1 | 2020 | 4058 | 0.020 |
Why?
|
Antipsychotic Agents | 1 | 2004 | 3077 | 0.020 |
Why?
|
Needs Assessment | 1 | 2016 | 1140 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2017 | 1756 | 0.020 |
Why?
|
Isomerism | 1 | 2010 | 197 | 0.020 |
Why?
|
Confidence Intervals | 1 | 1995 | 2915 | 0.020 |
Why?
|
Breast Diseases | 1 | 1993 | 436 | 0.020 |
Why?
|
Individuality | 1 | 1991 | 303 | 0.020 |
Why?
|
Metabolic Diseases | 1 | 2016 | 686 | 0.020 |
Why?
|
Saphenous Vein | 1 | 2012 | 519 | 0.020 |
Why?
|
Hydroxymethylglutaryl-CoA Synthase | 1 | 1989 | 15 | 0.020 |
Why?
|
Nicotinic Acids | 1 | 1988 | 33 | 0.020 |
Why?
|
Blood Preservation | 1 | 1989 | 169 | 0.020 |
Why?
|
Creatine | 1 | 2011 | 424 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2000 | 4342 | 0.020 |
Why?
|
Evidence-Based Medicine | 2 | 2012 | 3690 | 0.020 |
Why?
|
Potassium, Dietary | 2 | 2003 | 103 | 0.020 |
Why?
|
Homozygote | 2 | 2005 | 1774 | 0.020 |
Why?
|
Diastole | 2 | 2001 | 785 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2017 | 1750 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2021 | 7119 | 0.020 |
Why?
|
Subcutaneous Fat | 1 | 2012 | 401 | 0.020 |
Why?
|
Point-of-Care Systems | 1 | 2017 | 1218 | 0.020 |
Why?
|
Transportation | 1 | 1989 | 217 | 0.020 |
Why?
|
Protein Isoforms | 2 | 2004 | 1716 | 0.020 |
Why?
|
Creatinine | 2 | 2004 | 1916 | 0.020 |
Why?
|
Tissue Plasminogen Activator | 1 | 1993 | 1164 | 0.020 |
Why?
|
Professional Practice | 1 | 1990 | 314 | 0.020 |
Why?
|
Pneumonia | 1 | 1979 | 2159 | 0.020 |
Why?
|
Mitochondria | 1 | 2021 | 3672 | 0.020 |
Why?
|
Mice, Inbred C57BL | 3 | 2012 | 22341 | 0.020 |
Why?
|
Models, Molecular | 1 | 2017 | 5382 | 0.020 |
Why?
|
Oleic Acid | 1 | 1987 | 88 | 0.020 |
Why?
|
ROC Curve | 1 | 2014 | 3614 | 0.020 |
Why?
|
Androgens | 1 | 1994 | 1278 | 0.020 |
Why?
|
Peritoneal Cavity | 1 | 1987 | 135 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 1996 | 2006 | 0.020 |
Why?
|
Blood Coagulation | 1 | 1992 | 1169 | 0.020 |
Why?
|
Blood Platelets | 2 | 2001 | 2464 | 0.020 |
Why?
|
Medication Adherence | 1 | 2018 | 2190 | 0.020 |
Why?
|
Iron | 1 | 2014 | 1811 | 0.020 |
Why?
|
Linoleic Acid | 1 | 1987 | 158 | 0.020 |
Why?
|
Rats | 2 | 2016 | 23717 | 0.020 |
Why?
|
Retrospective Studies | 5 | 2020 | 81565 | 0.020 |
Why?
|
Isoprostanes | 1 | 2005 | 21 | 0.020 |
Why?
|
Angioplasty, Balloon | 1 | 1989 | 591 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 1989 | 1479 | 0.020 |
Why?
|
Taq Polymerase | 1 | 2005 | 20 | 0.020 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2008 | 707 | 0.020 |
Why?
|
Medical Records | 1 | 2011 | 1408 | 0.020 |
Why?
|
Terminology as Topic | 1 | 2012 | 1536 | 0.020 |
Why?
|
Specimen Handling | 1 | 1989 | 704 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 1995 | 3722 | 0.010 |
Why?
|
Computational Biology | 1 | 2017 | 3565 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2011 | 3432 | 0.010 |
Why?
|
Apoprotein(a) | 1 | 2004 | 17 | 0.010 |
Why?
|
Patient Education as Topic | 1 | 2014 | 2332 | 0.010 |
Why?
|
Site-Specific DNA-Methyltransferase (Adenine-Specific) | 1 | 2004 | 18 | 0.010 |
Why?
|
Genetic Loci | 1 | 2013 | 2630 | 0.010 |
Why?
|
Testosterone | 1 | 1995 | 2495 | 0.010 |
Why?
|
Fatty Acids, Nonesterified | 1 | 1986 | 393 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2016 | 13400 | 0.010 |
Why?
|
Interviews as Topic | 1 | 2012 | 2741 | 0.010 |
Why?
|
Vasodilation | 1 | 2008 | 969 | 0.010 |
Why?
|
Women's Health | 1 | 1993 | 2081 | 0.010 |
Why?
|
Mental Disorders | 1 | 2004 | 6871 | 0.010 |
Why?
|
Microcirculation | 1 | 2008 | 1282 | 0.010 |
Why?
|
Algorithms | 2 | 1996 | 14066 | 0.010 |
Why?
|
Pilot Projects | 2 | 1996 | 8724 | 0.010 |
Why?
|
Natriuresis | 1 | 2003 | 106 | 0.010 |
Why?
|
Protease Inhibitors | 1 | 1987 | 750 | 0.010 |
Why?
|
Antigens, CD1 | 1 | 2005 | 434 | 0.010 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2005 | 588 | 0.010 |
Why?
|
Nutrition Surveys | 1 | 2010 | 1735 | 0.010 |
Why?
|
Endosomes | 1 | 2005 | 521 | 0.010 |
Why?
|
Glutamine | 1 | 2005 | 575 | 0.010 |
Why?
|
Physicians | 2 | 2004 | 4591 | 0.010 |
Why?
|
Hypotension | 1 | 1988 | 885 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2017 | 12775 | 0.010 |
Why?
|
Ligands | 1 | 2008 | 3274 | 0.010 |
Why?
|
Minerals | 1 | 2003 | 278 | 0.010 |
Why?
|
MAP Kinase Signaling System | 1 | 2008 | 1490 | 0.010 |
Why?
|
Creatine Kinase | 1 | 2003 | 682 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2017 | 9527 | 0.010 |
Why?
|
Mass Screening | 1 | 1996 | 5450 | 0.010 |
Why?
|
Myocardial Revascularization | 1 | 2004 | 795 | 0.010 |
Why?
|
Self Report | 1 | 2012 | 3769 | 0.010 |
Why?
|
Sex Distribution | 1 | 2005 | 2270 | 0.010 |
Why?
|
Time | 1 | 2002 | 549 | 0.010 |
Why?
|
Data Collection | 1 | 2009 | 3318 | 0.010 |
Why?
|
Internet | 1 | 2012 | 3107 | 0.010 |
Why?
|
Age Distribution | 1 | 2005 | 2865 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2008 | 2455 | 0.010 |
Why?
|
Nitric Oxide | 1 | 2008 | 2142 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2003 | 1588 | 0.010 |
Why?
|
Syndrome | 1 | 2005 | 3270 | 0.010 |
Why?
|
Survivors | 1 | 2009 | 2375 | 0.010 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2008 | 2877 | 0.010 |
Why?
|
Serum Amyloid A Protein | 1 | 1998 | 127 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2008 | 2898 | 0.010 |
Why?
|
Buttocks | 1 | 1998 | 111 | 0.010 |
Why?
|
Cats | 1 | 1999 | 972 | 0.010 |
Why?
|
Demography | 1 | 2002 | 1641 | 0.010 |
Why?
|
Reactive Oxygen Species | 1 | 2005 | 2144 | 0.010 |
Why?
|
Guinea Pigs | 1 | 1998 | 1300 | 0.010 |
Why?
|
Isoenzymes | 1 | 2001 | 1688 | 0.010 |
Why?
|
Fibroblasts | 1 | 1987 | 4162 | 0.010 |
Why?
|
Normal Distribution | 1 | 1996 | 267 | 0.010 |
Why?
|
Epidemiologic Studies | 1 | 1999 | 677 | 0.010 |
Why?
|
Cattle | 1 | 1981 | 3801 | 0.010 |
Why?
|
Fish Products | 1 | 1975 | 31 | 0.010 |
Why?
|
Skinfold Thickness | 1 | 1975 | 164 | 0.010 |
Why?
|
Acute Disease | 1 | 2005 | 7237 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2005 | 2689 | 0.010 |
Why?
|
Vitamins | 1 | 2003 | 1631 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2005 | 5503 | 0.010 |
Why?
|
Glucose Intolerance | 1 | 1998 | 578 | 0.010 |
Why?
|
Nurses | 2 | 1998 | 2503 | 0.010 |
Why?
|
Dendritic Cells | 1 | 2005 | 2747 | 0.010 |
Why?
|
Social Conditions | 1 | 1974 | 118 | 0.010 |
Why?
|
Cost Control | 1 | 1996 | 626 | 0.010 |
Why?
|
Chromatography, Gas | 1 | 1994 | 150 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1996 | 1724 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2008 | 4054 | 0.010 |
Why?
|
Gene Deletion | 1 | 2001 | 2667 | 0.010 |
Why?
|
Liver Diseases | 1 | 2002 | 1304 | 0.010 |
Why?
|
Gastrointestinal Diseases | 1 | 2002 | 1204 | 0.010 |
Why?
|
Safety | 1 | 1998 | 1157 | 0.010 |
Why?
|
Ischemic Attack, Transient | 1 | 1999 | 871 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2005 | 4556 | 0.010 |
Why?
|
Mutation | 1 | 2018 | 30209 | 0.010 |
Why?
|
Fibrinopeptide A | 1 | 1992 | 43 | 0.010 |
Why?
|
Protein S | 1 | 1992 | 29 | 0.010 |
Why?
|
Antithrombin III | 1 | 1992 | 128 | 0.010 |
Why?
|
Protein C | 1 | 1992 | 134 | 0.010 |
Why?
|
Prothrombin | 1 | 1992 | 193 | 0.010 |
Why?
|
Neoplasms | 1 | 2001 | 22344 | 0.010 |
Why?
|
Factor Xa | 1 | 1992 | 165 | 0.010 |
Why?
|
Bleeding Time | 1 | 1991 | 83 | 0.010 |
Why?
|
Absorption | 1 | 1991 | 242 | 0.010 |
Why?
|
Breast Neoplasms | 2 | 2002 | 21074 | 0.010 |
Why?
|
Up-Regulation | 1 | 2000 | 4133 | 0.010 |
Why?
|
Models, Statistical | 1 | 2005 | 5089 | 0.010 |
Why?
|
Lymphoma | 1 | 1999 | 1896 | 0.010 |
Why?
|
Arachidonic Acids | 1 | 1990 | 294 | 0.010 |
Why?
|
Thrombin | 1 | 1992 | 601 | 0.010 |
Why?
|
Adjuvants, Immunologic | 1 | 1995 | 993 | 0.010 |
Why?
|
Arachidonic Acid | 1 | 1990 | 429 | 0.000 |
Why?
|
Databases, Factual | 1 | 2004 | 8062 | 0.000 |
Why?
|
Tablets | 1 | 1988 | 149 | 0.000 |
Why?
|
Cost-Benefit Analysis | 1 | 2001 | 5531 | 0.000 |
Why?
|
T-Lymphocytes | 1 | 2005 | 10260 | 0.000 |
Why?
|
Platelet Aggregation | 1 | 1991 | 769 | 0.000 |
Why?
|
Stress, Mechanical | 1 | 1993 | 1670 | 0.000 |
Why?
|
Colonic Neoplasms | 1 | 1999 | 2532 | 0.000 |
Why?
|
Radiography | 1 | 1998 | 6943 | 0.000 |
Why?
|
Antigens | 1 | 1992 | 1437 | 0.000 |
Why?
|
Solubility | 1 | 1988 | 1077 | 0.000 |
Why?
|
Coronary Circulation | 1 | 1993 | 1601 | 0.000 |
Why?
|
Hormones | 1 | 1989 | 865 | 0.000 |
Why?
|
Vitamin E | 1 | 1989 | 872 | 0.000 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1988 | 1527 | 0.000 |
Why?
|
Delayed-Action Preparations | 1 | 1988 | 966 | 0.000 |
Why?
|
Residence Characteristics | 1 | 1974 | 2116 | 0.000 |
Why?
|
Melanoma | 1 | 1999 | 5695 | 0.000 |
Why?
|
Skin | 1 | 1993 | 4482 | 0.000 |
Why?
|
Quality of Life | 1 | 2001 | 13468 | 0.000 |
Why?
|
Computer Simulation | 1 | 1993 | 6254 | 0.000 |
Why?
|
Lung Neoplasms | 1 | 1999 | 13483 | 0.000 |
Why?
|
Child, Preschool | 1 | 1974 | 42511 | 0.000 |
Why?
|
Child | 1 | 1974 | 80573 | 0.000 |
Why?
|